114 related articles for article (PubMed ID: 11268453)
1. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
[TBL] [Abstract][Full Text] [Related]
2. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
Kobayashi H; Ishii Y; Takayama T
J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
[TBL] [Abstract][Full Text] [Related]
3. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
Younes M; Juarez D; Lechago LV; Lerner SP
Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
[TBL] [Abstract][Full Text] [Related]
4. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia.
Younes M; Ertan A; Lechago LV; Somoano J; Lechago J
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):303-5. PubMed ID: 9149888
[TBL] [Abstract][Full Text] [Related]
5. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival.
Baer S; Casaubon L; Schwartz MR; Marcogliese A; Younes M
Laryngoscope; 2002 Feb; 112(2):393-6. PubMed ID: 11889403
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Younes M; Lechago LV; Lechago J
Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
[TBL] [Abstract][Full Text] [Related]
8. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
Wang T; Sun YE; Tian JH; Liu XB; Yao SL; Wang K
Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):913-6. PubMed ID: 14728832
[TBL] [Abstract][Full Text] [Related]
10. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
[TBL] [Abstract][Full Text] [Related]
11. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma].
Liu AJ; Hou N; Chen LZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):398-400. PubMed ID: 12940086
[TBL] [Abstract][Full Text] [Related]
12. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R
Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Hiyoshi Y; Watanabe M; Imamura Y; Nagai Y; Baba Y; Yoshida N; Toyama E; Hayashi N; Baba H
Oncology; 2009; 76(4):286-92. PubMed ID: 19262068
[TBL] [Abstract][Full Text] [Related]
14. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS
Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091
[TBL] [Abstract][Full Text] [Related]
15. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
[TBL] [Abstract][Full Text] [Related]
16. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H
Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596
[TBL] [Abstract][Full Text] [Related]
17. [Expression of annexin I in different histological types of carcinomas].
Xue LY; Teng LH; Zou SM; Ren LQ; Zheng S; Luo W; Bi R; Lü N
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):444-8. PubMed ID: 17974280
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
20. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
Kim YW; Park YK; Yoon TY; Lee SM
Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]